Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	14.5	6.79	1.18	2.75	28.9	20.8
Short-Term Investments	-	-	25	25	-	-
Trading Asset Securities	-	-	8.73	3.91	1.19	2.48
Cash & Short-Term Investments	14.5	6.79	34.91	31.66	30.09	23.28
Cash Growth	855.66%	-80.56%	10.26%	5.22%	29.25%	94.62%
Accounts Receivable	567.29	181.37	0.13	1.9	12.32	13.81
Other Receivables	-	1.58	2.83	3.66	3.89	4.76
Receivables	655.09	253.18	2.97	6.34	20.38	42.22
Inventory	30.56	8.43	3.21	4.29	8.77	6.78
Prepaid Expenses	-	0.18	0.01	0.13	0.08	0.02
Other Current Assets	6.04	0.75	0.2	-	-0	1
Total Current Assets	706.2	269.33	41.3	42.43	59.31	73.3
Property, Plant & Equipment	4.19	1.86	1.18	1.74	4.55	16.2
Long-Term Investments	0.43	0.43	30.64	27.75	4.22	3.9
Other Intangible Assets	7.1	0	0	0	0.11	0.32
Long-Term Deferred Tax Assets	0.12	0.45	0.54	0.65	0.66	-
Other Long-Term Assets	-	0	-	-	18.54	2
Total Assets	718.03	272.06	73.65	72.57	87.38	95.73
Accounts Payable	454.94	93.01	0.03	0.54	8.83	21.46
Accrued Expenses	-	3.36	0.07	0.07	0.09	0.13
Current Portion of Long-Term Debt	-	-	-	-	0.34	-
Current Income Taxes Payable	-	0.3	-	-	-	-
Other Current Liabilities	7	-	0	0.01	0.05	0.16
Total Current Liabilities	461.94	96.67	0.1	0.62	9.29	21.75
Long-Term Debt	-	-	-	-	1.31	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.33
Total Liabilities	461.94	96.67	0.1	0.62	10.6	22.08
Common Stock	144.8	99.5	81	81	81	81
Additional Paid-In Capital	-	94.65	12.15	12.15	12.15	12.15
Retained Earnings	-	-18.76	-19.6	-24.32	-22.74	-28.14
Comprehensive Income & Other	111.3	-	-	3.12	3.63	3.63
Total Common Equity	256.1	175.39	73.55	71.95	74.04	68.65
Minority Interest	-	-	-	-	2.74	5.01
Shareholders' Equity	256.1	175.39	73.55	71.95	76.78	73.65
Total Liabilities & Equity	718.03	272.06	73.65	72.57	87.38	95.73
Total Debt	-	-	-	-	1.65	-
Net Cash (Debt)	14.5	6.79	34.91	31.66	28.44	23.28
Net Cash Growth	855.66%	-80.56%	10.26%	11.31%	22.18%	442.70%
Net Cash Per Share	1.16	0.72	3.35	3.91	3.51	2.87
Filing Date Shares Outstanding	14.41	9.95	8.1	8.1	8.1	8.1
Total Common Shares Outstanding	14.41	9.95	8.1	8.1	8.1	8.1
Working Capital	244.26	172.66	41.2	41.81	50.02	51.55
Book Value Per Share	17.77	17.63	9.08	8.88	9.14	8.47
Tangible Book Value	249	175.39	73.55	71.95	73.93	68.32
Tangible Book Value Per Share	17.28	17.63	9.08	8.88	9.13	8.43
Buildings	-	-	1.43	1.43	1.43	-
Machinery	-	-	11.85	12.04	14.54	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.